Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
National Cancer Institute (NCI)
Title:
Assessment of Bone Mineral Density in People Living with HIV and KSHV Associated Malignancies: A Retrospective Longitudinal Analysis
Study Description:
This is a retrospective review that includes all participants with human immunodeficiency virus (HIV) (PWH) affected by Kaposi sarcoma (KS), KSHV-associated multicentric Castleman disease, and KSHV associated inflammatory cytokine syndrome enrolled on the tissue procurement study (01-C-0038) and other treatment protocols within the HIV/AIDS Malignancy Branch at the National Cancer Institute (NCI) from 1/1/2005 to 12/1/2020.
Objectives:
To determine the factors that are associated with bone mineral density (BMD) loss in PWH and KSHV associated malignancies.
Study Population:
All patients seen at the NIH from 1/1/2005 to 12/1/2020.
Description of Sites/Facilities conducting research:
This is a single site study initiated by the HIV/AIDS Malignancy Branch at the National Cancer Institute
Study Duration:
Data abstraction to completion of data analyses will take about 2 years.
Age
18–99
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
STUDY POPULATION:
Subjects will not be recruited for this study; however, participants' records will be selected from treatment protocols from 1/1/2005 to 12/1/2020 unless the subject opted out of the future use of his/her data. These subjects enrolled to natural history and/or treatment protocols within the HIV/AIDS Malignancy Branch on the basis of a diagnosis of HIV and KSHV-associated conditions, such as KS alone, in combination with KSHV-MCD or KICS.
As this is a retrospective longitudinal study, the investigators will review the data from subjects who have at least two completed CT scans to measure bone mineral density.